4.39 USD
▼+0.04-1.41%
2026-08-03
市值
$85.66M
市盈率
—
EPS
-0.06
股息率
—
52 周区间
2.66 – 5.89
成交量
2.30K
Beta
-0.03
目标价
12.67
52W 低 2.6652W 高 5.89
价格走势
公司简介
Alterity Therapeutics Limited is engages in research and development of Parkinsonian and neurodegenerative disorders, including Multiple System Atrophy (MSA) and Parkinson’s disease. The company’s lead drug candidate is ATH434, a small molecule drug candidate that has completed Phase II clinical trial for the treatment of Parkinson’s disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage; and ATH434-202 that is in Phase II clinical trial to treat multiple system atrophy, as we...